COVID-19 UPDATES: Find news and resources for audiologists, speech-language pathologists, and the public. 
Latest Updates | Telepractice Resources | Email Us | Chat With Action Center

Candidate for President-Elect: Paul R. Kileny, PhD, CCC-A

Why are you running for President-Elect on the ASHA Board of Directors?


The ASHA Leader asked the candidates:

What is your top priority if elected to the ASHA Board of Directors?

ASHA is a dynamic and diverse organization, composed of highly skilled clinical providers, scientists, and teachers. I have spent my career balancing those three missions, and would like to use my leadership experience to help enhance the image of our professions in public, professional, and political arenas. This is an era of expected disruptions associated with political, professional, economic, and technological events. I am motivated to help guide our professions during these times of change, recognize obstacles and opportunities, and ascertain that we react appropriately for the benefit of our patients and providers. We need to supplement our practices with components such as telehealth and artificial intelligence-driven practice, maintain our professional autonomy, defend our credentials, and advocate for fair and equitable reimbursement.

After serving as director of audiology at the Glenrose Hospital in Edmonton, Alberta, Canada, Paul R. Kileny, PhD, CCC-A, joined the University of Michigan Department of Otolaryngology faculty as director of audiology and electrophysiology in 1985. He was promoted to professor with tenure in 1992. He received his doctorate in audiology (AuD) from the University of Iowa and holds undergraduate and master’s degrees in audiology and speech-language pathology from the Sackler School of Medicine, Tel Aviv. He is a licensed and certified audiologist (holds the ASHA Certificate of Clinical Competence in Audiology [CCC-AUD]) and is a Board-Certified Specialist in Intraoperative Monitoring (BCS-IOM). 

Dr. Kileny has dedicated his career to the development, advancement, and innovation of the clinical practice of audiology. In 1979, he established one of the first auditory brainstem response (ABR) newborn hearing screening programs in North America. At the University of Michigan, he co-founded the Cochlear Implant Program and established two programs—the Newborn Hearing Screening Program and the Neurophysiologic Intraoperative Monitoring Program. He has received multiple National Institutes of Health (NIH) grants and is currently co-investigator on a study investigating the promotion of early direct referral of patients to audiology. Dr. Kileny remains an active clinician, which inspires his research, and also engages in professional advocacy.

Dr. Kileny has authored more than 160 journal articles, book chapters, and lectures internationally. He is an ASHA Fellow and is the recipient of several awards, including the American Academy of Audiology (AAA) Career Award in Hearing, the Presidential Citation of the American Otological Society, ASHA Honors of the Association, and 2019 Distinguished Alumnus at the University of Iowa. He served on ASHA’s Ad Hoc Committee on Advances in Clinical Practice, which resulted in the inclusion of cochlear implants and intraoperative monitoring into the most current version of ASHA’s Scope of Practice in Audiology. Dr. Kileny has served on the ASHA Government Relations and Public Policy Board (serving as chair during his last year of tenure) and on the ASHA Committee on Honors (as vice-chair). He is past vice-chair of the Michigan Board of Audiology.

ASHA Corporate Partners